D.E. Shaw & Co’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $945K | Buy |
559,205
+89,879
| +19% | +$185K | ﹤0.01% | 3483 |
|
|
2025
Q4 | $929K | Buy |
+469,326
| New | +$1.5M | ﹤0.01% | 3595 |
|
|
2023
Q4 | – | Sell |
-16,553
| Closed | -$275K | – | 4579 |
|
|
2023
Q3 | $275K | Buy |
16,553
+3,417
| +26% | +$67.7K | ﹤0.01% | 3648 |
|
|
2023
Q2 | $322K | Buy |
+13,136
| New | +$316K | ﹤0.01% | 3577 |
|
|
2022
Q2 | – | Sell |
-44,400
| Closed | -$1.12M | – | 5720 |
|
|
2022
Q1 | $1.65M | Buy |
+44,400
| New | +$1.88M | ﹤0.01% | 3495 |
|
|
2021
Q4 | – | Sell |
-49,269
| Closed | -$2.58M | – | 5679 |
|
|
2021
Q3 | $3.06M | Sell |
49,269
-10,721
| -18% | -$895K | ﹤0.01% | 2608 |
|
|
2021
Q2 | $5.13M | Buy |
+59,990
| New | +$3.21M | ﹤0.01% | 2015 |
|
|
2018
Q4 | – | Sell |
-11,778
| Closed | -$12K | – | 3960 |
|
|
2018
Q3 | $12K | Sell |
11,778
-977
| -8% | -$1.49K | ﹤0.01% | 3682 |
|
|
2018
Q2 | $26K | Sell |
12,755
-2,902
| -19% | -$24.9K | ﹤0.01% | 3663 |
|
|
2018
Q1 | $111K | Sell |
15,657
-2,300
| -13% | -$15.5K | ﹤0.01% | 3384 |
|
|
2017
Q4 | $72K | Sell |
17,957
-600
| -3% | -$2.42K | ﹤0.01% | 3516 |
|
|
2017
Q3 | $76K | Hold |
18,557
| – | – | ﹤0.01% | 3385 |
|
|
2017
Q2 | $76K | Sell |
18,557
-4,226
| -19% | -$19.9K | ﹤0.01% | 3283 |
|
|
2017
Q1 | $142K | Sell |
22,783
-17,159
| -43% | -$77.9K | ﹤0.01% | 3168 |
|
|
2016
Q4 | $160K | Sell |
39,942
-7,354
| -16% | -$34.1K | ﹤0.01% | 3302 |
|
|
2016
Q3 | $331K | Sell |
47,296
-6,790
| -13% | -$113K | ﹤0.01% | 3003 |
|
|
2016
Q2 | $829K | Sell |
54,086
-2,192
| -4% | -$34.8K | ﹤0.01% | 2521 |
|
|
2016
Q1 | $879K | Buy |
56,278
+157
| +0.3% | +$2.03K | ﹤0.01% | 2436 |
|
|
2015
Q4 | $688K | Hold |
56,121
| – | – | ﹤0.01% | 2885 |
|
|
2015
Q3 | $719K | Sell |
56,121
-1,749
| -3% | -$22.1K | ﹤0.01% | 2829 |
|
|
2015
Q2 | $701K | Sell |
57,870
-11,372
| -16% | -$156K | ﹤0.01% | 2949 |
|
|
2015
Q1 | $916K | Sell |
69,242
-1,518
| -2% | -$20.5K | ﹤0.01% | 2636 |
|
|
2014
Q4 | $1.01M | Buy |
70,760
+21,784
| +44% | +$377K | ﹤0.01% | 2828 |
|
|
2014
Q3 | $1.34M | Sell |
48,976
-11,839
| -19% | -$360K | ﹤0.01% | 2569 |
|
|
2014
Q2 | $2.45M | Buy |
60,815
+11,185
| +23% | +$414K | ﹤0.01% | 2146 |
|
|
2014
Q1 | $1.91M | Buy |
49,630
+13,987
| +39% | +$494K | ﹤0.01% | 2446 |
|
|
2013
Q4 | $1.21M | Buy |
35,643
+3,520
| +11% | +$93.5K | ﹤0.01% | 3000 |
|
|
2013
Q3 | $612K | Buy |
32,123
+1,047
| +3% | +$18.3K | ﹤0.01% | 3424 |
|
|
2013
Q2 | $481K | Buy |
+31,076
| New | +$657K | ﹤0.01% | 3279 |
|
Other funds holding FLNA
VCM
GC
D.E. Shaw & Co's FLNA Position: Q1 2026 in Review
D.E. Shaw & Co increased its Filana Therapeutics (FLNA) stake by 19% in Q1 2026, buying an estimated $185K and bringing the position to 559,205 shares worth $945K. The position accounts for ﹤0.01% of the portfolio, ranked #3483.
D.E. Shaw & Co first reported a position in FLNA in Q2 2013 and has held it in 29 quarters since. The position peaked at $5.13M in Q2 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.
- D.E. Shaw & Co held 559,205 shares of Filana Therapeutics worth $945K as of Q1 2026.
- D.E. Shaw & Co bought 89,879 Filana Therapeutics shares in Q1 2026, an estimated $185K.
- Filana Therapeutics made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3483 holding.
- D.E. Shaw & Co first reported a position in Filana Therapeutics in Q2 2013 and has held it in 29 quarters since.
- D.E. Shaw & Co's Filana Therapeutics position peaked at $5.13M in Q2 2021.
- 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.